Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Treatment options like buprenorphine are rendered less effective by the prevalence of fentanyl, xylazine and other synthetic drugs.
NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care.
Addiction is a chronic illness requiring constant vigilance, and relapses are part of the journey to recovery.
Study findings support the continuation of telehealth services for opioid use disorder and related care.
Changes will affect nursing home and hospital staffing, delivery of addiction treatment and COVID data reporting.
These data are consistent with a recent study reporting expansion was not associated with an increase in methadone-involved overdose deaths.
Authorities encourage more health care providers to prescribe buprenorphine for people trying to overcome opioid addiction.
The potentially lifesaving prescription drug buprenorphine is less available to women and Black and Latino people with opioid addiction.
Overdose deaths rose by nearly 5% in 2019, and the pandemic could make matters worse.
This is one of many ways that people who use drugs can engage in harm reduction during the coronavirus pandemic.
A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.
Experts are calling for greater flexibility in clinicians’ ability to deliver treatments for opioid use disorder.
One bill would create 1,000 new residency positions for physicians going into addiction treatment medicine.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
Researchers found critical gaps in the scientific knowledge about the opioid epidemic.
Researchers analyzed rates of use of buprenorphine, which is used to treat opioid use disorder, between 2009 and 2018.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.